| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/27/2015 | US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 01/27/2015 | US8940691 Method for treating metabolic disorders including type 1 and type 2 diabetes mellitus |
| 01/27/2015 | US8940684 Cross-linked collagen comprising an antifungal agent |
| 01/27/2015 | US8940683 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 01/27/2015 | US8940532 Biological graft transferring instrument and method for transferring biological graft |
| 01/27/2015 | US8940394 Protein imprinting by means of alginate-based polymers |
| 01/27/2015 | US8940393 Mannitol crystal powder having a low fine-particle content, and method for producing same |
| 01/27/2015 | US8940339 Microemulsions and its use for preventing airway diseases |
| 01/27/2015 | US8940338 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 01/27/2015 | US8940337 Transparent bacterial cellulose nanocomposite hydrogels |
| 01/27/2015 | US8940336 Polymer particles prepared from polymerisable alkylene glycol (meth) acrylate monomers |
| 01/27/2015 | US8940335 Process for making dry and stable hemostatic compositions |
| 01/27/2015 | US8940334 Pharmaceutical composition of an anthracycline |
| 01/27/2015 | US8940333 Amphiphilic block copolymers and nanoparticles comprising the same |
| 01/27/2015 | US8940332 High-molecular weight conjugate of podophyllotoxins |
| 01/27/2015 | US8940331 Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells |
| 01/27/2015 | US8940330 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| 01/27/2015 | US8940329 High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms |
| 01/27/2015 | US8940328 Pellet formulation for the treatment of the intestinal tract |
| 01/27/2015 | US8940327 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 01/27/2015 | US8940326 Transdermal patch and method for delivery of vitamin B12 |
| 01/27/2015 | US8940324 Octenidine composition |
| 01/27/2015 | US8940321 Compositions for treatment of ear disorders and methods of use thereof |
| 01/27/2015 | US8940319 Formulations, devices and methods for treating and preventing mucositis |
| 01/27/2015 | US8940318 Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release |
| 01/27/2015 | US8940316 Osmotic delivery comprising an insulinotropic peptide and uses thereof |
| 01/27/2015 | US8940315 Benzodiazepine formulation in a polyorthoester carrier |
| 01/27/2015 | US8940312 Composition containing polyunsaturated fatty acid |
| 01/27/2015 | US8940311 In situ controlled release drug delivery system |
| 01/27/2015 | US8940305 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/27/2015 | US8940295 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
| 01/27/2015 | US8940281 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications |
| 01/27/2015 | US8940271 Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| 01/27/2015 | US8940018 High strength suture with absorbable core and suture anchor combination |
| 01/27/2015 | US8939948 Ocular insert apparatus and methods |
| 01/27/2015 | US8939748 Method for the production of a form of administration of a medicament |
| 01/27/2015 | CA2820479C Patch and method for producing the same |
| 01/27/2015 | CA2781120C Lyophilization methods, compositions, and kits |
| 01/27/2015 | CA2763676C A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
| 01/27/2015 | CA2687794C Spherical particle of crystalline mannitol |
| 01/27/2015 | CA2664893C Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors |
| 01/27/2015 | CA2656788C Controlled release composition comprising polyurethane elastomers |
| 01/27/2015 | CA2651890C Controlled dose drug delivery system |
| 01/27/2015 | CA2648553C Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| 01/27/2015 | CA2647536C Non-homogenous dosage form coatings |
| 01/27/2015 | CA2584279C Compositions and methods for stabilizing liposomal drug formulations |
| 01/27/2015 | CA2549505C Oleaginous pharmaceutical and cosmetic foam |
| 01/26/2015 | CA2821870A1 Method to use a stable foam composed of bubbles of various food/supplement/cosmetic/pharmaceutical substances to increase the bio-availability of otherwise inert molecular hydrogen gas for medically useful health maintenance, health promotion, anti-aging and generalized disease process interference purposes in biological living systems in a manner which... |
| 01/22/2015 | WO2015010092A1 Heat-stable dry powder pharmaceutical compositions and methods |
| 01/22/2015 | WO2015009909A1 Novel nanoliposomes and their use for the treatment of amyloid protein diseases |
| 01/22/2015 | WO2015009799A1 Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose |
| 01/22/2015 | WO2015009566A1 Amorphous tecovirimat preparation |
| 01/22/2015 | WO2015009533A1 Gabaa receptor antagonists affecting ganglion cell function and visual function |
| 01/22/2015 | WO2015009330A1 Carbonate modified compositions for reduction of flue gas resistivity |
| 01/22/2015 | WO2015009146A1 Method and culture medium for in vitro culturing of stem cells |
| 01/22/2015 | WO2015009035A1 Tissue-repairing injectable preparation comprising a polymer obtained by polymerising hydrophobic biocompatible macromolecule and hydrophilic biocompatible macromolecule |
| 01/22/2015 | WO2015008849A1 Self-emulsifying composition of ω-3 fatty acid |
| 01/22/2015 | WO2015008848A1 SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID |
| 01/22/2015 | WO2015008825A1 Orally disintegrating tablet |
| 01/22/2015 | WO2015008748A1 Soft capsule coating |
| 01/22/2015 | WO2015008399A1 Soft capsule coating |
| 01/22/2015 | WO2015008301A1 Pharmaceutical composition for the treatment of diminution of bone tissue |
| 01/22/2015 | WO2015008169A2 Device, system and method for delivery of a long-acting drug |
| 01/22/2015 | WO2015007961A1 Polymerised cerium oxide nanoparticles in an active or bioactive network, protective topical treatments, methods for preparation thereof and uses thereof |
| 01/22/2015 | WO2015007912A1 Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drug |
| 01/22/2015 | WO2015007890A1 Pharmaceutical combinations of pregabalin |
| 01/22/2015 | WO2015007760A1 Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | WO2015007759A1 Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| 01/22/2015 | WO2015007676A1 Super quick disintegrating tablet formula for api miglitol |
| 01/22/2015 | WO2015007571A1 Powder mixtures for antibiotic dry syrup formulations |
| 01/22/2015 | WO2015007398A1 Method for preparing solid lipid nanoparticles containing antibodies in ion pair form using the fatty acid coacervation technique |
| 01/22/2015 | US20150025511 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150025509 Implantable Fluid Delivery Apparatus and Implantable Electrode |
| 01/22/2015 | US20150025496 Swallowable drug delivery device and method of delivery |
| 01/22/2015 | US20150025494 Drug delivery in association with medical or surgical procedures |
| 01/22/2015 | US20150025480 Composition for the transdermal delivery of fentanyl |
| 01/22/2015 | US20150025443 Topical compositions to treat circulatory disorders |
| 01/22/2015 | US20150025158 Novel thickening composition comprising pregelatinized waxy potato starch or pregelatinized cassava starch |
| 01/22/2015 | US20150025154 Ophthalmic composition |
| 01/22/2015 | US20150025151 Compositions and methods for reducing body fat |
| 01/22/2015 | US20150025149 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 01/22/2015 | US20150025146 Gastroretentive tablets |
| 01/22/2015 | US20150025139 Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
| 01/22/2015 | US20150025119 Release Application for Antihypertensive Agent on Plant Fiber Bundle |
| 01/22/2015 | US20150025112 Orally disintegrating tablet formulations of donepezil |
| 01/22/2015 | US20150025101 Opioid agonist/antagonist combinations |
| 01/22/2015 | US20150025096 Small molecule compounds to treat hearing loss |
| 01/22/2015 | US20150025084 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| 01/22/2015 | US20150025062 Hcn inhibitors affecting ganglion cell function and visual function |
| 01/22/2015 | US20150025051 Formulations for treating skin disorders |
| 01/22/2015 | US20150025024 Solid Compositions |
| 01/22/2015 | US20150025020 Self-preserved oil dispersions comprising boric acid |
| 01/22/2015 | US20150025010 Novel albumin-free factor viii formulations |
| 01/22/2015 | US20150025005 Self-regulated peptide hydrogel for insulin delivery |
| 01/22/2015 | US20150024996 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150024206 Coated devices and methods for coating |
| 01/22/2015 | US20150024113 Cold-Water Soluble Extruded Starch Product |
| 01/22/2015 | US20150024075 Phytocomposition for the treatment of pain related to joint diseases |
| 01/22/2015 | US20150024064 pKa Buffered Vitamin C Composition and Method |
| 01/22/2015 | US20150024060 Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production |